Clinical practice guideline update demonstrates benefits of hybrid closed-loop systems in pregnant women with type 1 diabetes, indicating enhanced prenatal care.
Notice of update The DDG clinical practice guidelines are updated regularly during the second half of the calendar year. Please ensure that you read and cite the respective current version. UPDATES TO CONTENT COMPARED TO THE PREVIOUS YEARʼS VERSION Change 1: In the section on insulin therapy, it is shown that hybrid closed-loop systems (HCLS) show potential in improving pregnancy care in pre-existing type 1 diabetes, based on the results of the AiDAPT and CRISTAL studies. Reason: AiDAPT, CRISTAL studies If applicable, supporting references: [ 1 ] Change 2: A checklist has been added at the end of the article. This provides a quick overview of all essential diagnostic and therapeutic measures. Publication History Article published online: 06 May 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Hummel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: